Atlas Trials

Intraoperative vs. Postoperative Intravesical Epirubicin Instillation for Prevention of Bladder Recurrence in High-Risk Upper Urinary Tract Urothelial Carcinoma

Clinical trial NCT06941038 · COMPLETED

Trial details

NCT number
NCT06941038
Sponsor
Ankara Etlik City Hospital
Status
COMPLETED
Study type
OBSERVATIONAL
Bladder Cancer RecurrenceIntravesical InstillationUpper Urinary Tract Carcinoma
Start date
2021-06-01
Primary completion
2024-04-01
Enrollment
270

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.